Results of bevacizumab as the primary treatment for retinal vein occlusions

Abstract

Intravitreal bevacizumab seems to be an effective primary treatment option for macular oedema due to retinal occlusions. Its main drawback is that multiple injections are necessary to maintain visual and anatomic improvements.